The report focuses on the Celecoxib market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Celecoxib market.
Major Players in the Celecoxib market are:
Anhui Heyi Chemical
Teva
Chengdu Suncadia Pharmaceuticals
Takeda
Mylan
Jiangsu Chiatai Qingjiang Pharmaceutical
Pfizer
On the basis of types, the Celecoxib market is primarily split into:
50mg Celecoxib
100mg Celecoxib
200mg Celecoxib
400mg Celecoxib
On the basis of applications, the market covers:
Rheumatoid Arthritis
Osteoarthritis
Acute Pain
Musculoskeletal Pain
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Celecoxib Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Celecoxib Market Overview
1.1 Product Overview and Scope of Celecoxib Market
1.2 Celecoxib Market Segment by Type
1.2.1 Global Celecoxib Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Celecoxib Market Segment by Application
1.3.1 Celecoxib Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Celecoxib Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Celecoxib (2017-2029)
1.5.1 Global Celecoxib Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Celecoxib Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Celecoxib Industry
1.7 Impact of Carbon Neutrality on the Celecoxib Industry
2 Celecoxib Market Upstream and Downstream Analysis
2.1 Celecoxib Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Celecoxib Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Anhui Heyi Chemical
3.1.1 Anhui Heyi Chemical Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Celecoxib Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Teva
3.2.1 Teva Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Celecoxib Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Chengdu Suncadia Pharmaceuticals
3.3.1 Chengdu Suncadia Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Celecoxib Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Takeda
3.4.1 Takeda Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Celecoxib Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Mylan
3.5.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Celecoxib Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Jiangsu Chiatai Qingjiang Pharmaceutical
3.6.1 Jiangsu Chiatai Qingjiang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Celecoxib Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Pfizer
3.7.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Celecoxib Market Performance (2017-2022)
3.7.4 Business Overview
4 Global Celecoxib Market Landscape by Player
4.1 Global Celecoxib Sales and Share by Player (2017-2022)
4.2 Global Celecoxib Revenue and Market Share by Player (2017-2022)
4.3 Global Celecoxib Average Price by Player (2017-2022)
4.4 Global Celecoxib Gross Margin by Player (2017-2022)
4.5 Celecoxib Market Competitive Situation and Trends
4.5.1 Celecoxib Market Concentration Rate
4.5.2 Celecoxib Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Celecoxib Sales, Revenue, Price Trend by Type
5.1 Global Celecoxib Sales and Market Share by Type (2017-2022)
5.2 Global Celecoxib Revenue and Market Share by Type (2017-2022)
5.3 Global Celecoxib Price by Type (2017-2022)
5.4 Global Celecoxib Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Celecoxib Sales, Revenue and Growth Rate of 50mg Celecoxib (2017-2022)
5.4.2 Global Celecoxib Sales, Revenue and Growth Rate of 100mg Celecoxib (2017-2022)
5.4.3 Global Celecoxib Sales, Revenue and Growth Rate of 200mg Celecoxib (2017-2022)
5.4.4 Global Celecoxib Sales, Revenue and Growth Rate of 400mg Celecoxib (2017-2022)
6 Global Celecoxib Market Analysis by Application
6.1 Global Celecoxib Consumption and Market Share by Application (2017-2022)
6.2 Global Celecoxib Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Celecoxib Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Celecoxib Consumption and Growth Rate of Rheumatoid Arthritis (2017-2022)
6.3.2 Global Celecoxib Consumption and Growth Rate of Osteoarthritis (2017-2022)
6.3.3 Global Celecoxib Consumption and Growth Rate of Acute Pain (2017-2022)
6.3.4 Global Celecoxib Consumption and Growth Rate of Musculoskeletal Pain (2017-2022)
6.3.5 Global Celecoxib Consumption and Growth Rate of Others (2017-2022)
7 Global Celecoxib Sales and Revenue Region Wise (2017-2022)
7.1 Global Celecoxib Sales and Market Share, Region Wise (2017-2022)
7.2 Global Celecoxib Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Celecoxib Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Celecoxib Market Forecast (2022-2029)
8.1 Global Celecoxib Sales, Revenue Forecast (2022-2029)
8.1.1 Global Celecoxib Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Celecoxib Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Celecoxib Price and Trend Forecast (2022-2029)
8.2 Global Celecoxib Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Celecoxib Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Celecoxib Sales and Revenue Forecast (2022-2029)
8.2.3 China Celecoxib Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Celecoxib Sales and Revenue Forecast (2022-2029)
8.2.5 India Celecoxib Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Celecoxib Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Celecoxib Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Celecoxib Sales and Revenue Forecast (2022-2029)
8.3 Global Celecoxib Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Celecoxib Revenue and Growth Rate of 50mg Celecoxib (2022-2029)
8.3.2 Global Celecoxib Revenue and Growth Rate of 100mg Celecoxib (2022-2029)
8.3.3 Global Celecoxib Revenue and Growth Rate of 200mg Celecoxib (2022-2029)
8.3.4 Global Celecoxib Revenue and Growth Rate of 400mg Celecoxib (2022-2029)
8.4 Global Celecoxib Consumption Forecast by Application (2022-2029)
8.4.1 Global Celecoxib Consumption Value and Growth Rate of Rheumatoid Arthritis (2022-2029)
8.4.2 Global Celecoxib Consumption Value and Growth Rate of Osteoarthritis (2022-2029)
8.4.3 Global Celecoxib Consumption Value and Growth Rate of Acute Pain (2022-2029)
8.4.4 Global Celecoxib Consumption Value and Growth Rate of Musculoskeletal Pain (2022-2029)
8.4.5 Global Celecoxib Consumption Value and Growth Rate of Others (2022-2029)
8.5 Celecoxib Market Forecast Under COVID-19
9 Industry Outlook
9.1 Celecoxib Market Drivers Analysis
9.2 Celecoxib Market Restraints and Challenges
9.3 Celecoxib Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Celecoxib Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Celecoxib Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Celecoxib Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Methylprednisolone Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases.
The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
Methylprednisolone is a widely used medication, and The market trend invol......
Global Ibuprofen Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 84
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030.
Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
Global Mesalazine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 132
According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
Global Drugs For Sinusitis Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
Global Celecoxib Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period.
The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
Global Ibuprofen Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period.
The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
Global Ketoprofen Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period.
The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 114
Market Overview of Global Drugs for Sinusitis market:
According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 91
According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period.
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Market competitio......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
